EMA grants positive opinion for orphan drug status for ovarian cancer oncolytic vaccine

OXFORD – 13 January 2015 PsiOxus Therapeutics Ltd. (PsiOxus), an Oxford, UK based biotechnology company developing innovative new treatments for cancer, has been granted a positive opinion from the European… read more →